---
title: "KinLong released its 2024 annual performance, with a net profit attributable to the parent company of 89.9892 million yuan, a year-on-year decrease of 72.23%"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/233470550.md"
description: "KinLong released its 2024 annual report, with operating revenue of 6.638 billion yuan, a year-on-year decrease of 14.92%; net profit attributable to shareholders of the parent company was 89.9892 million yuan, a year-on-year decrease of 72.23%; net profit excluding non-recurring gains and losses was 47.4827 million yuan, a year-on-year decrease of 83.54%. The basic earnings per share were 0.27 yuan, and it plans to distribute a cash dividend of 2 yuan (including tax) for every 10 shares to all shareholders"
datetime: "2025-03-27T13:38:05.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/233470550.md)
  - [en](https://longbridge.com/en/news/233470550.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/233470550.md)
---

# KinLong released its 2024 annual performance, with a net profit attributable to the parent company of 89.9892 million yuan, a year-on-year decrease of 72.23%

According to the Zhitong Finance APP, KinLong (002791.SZ) released its annual report for 2024. During the reporting period, the company achieved operating revenue of 6.638 billion yuan, a year-on-year decrease of 14.92%. The net profit attributable to shareholders of the listed company was 89.9892 million yuan, a year-on-year decrease of 72.23%. The net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 47.4827 million yuan, a year-on-year decrease of 83.54%. The basic earnings per share were 0.27 yuan. It is proposed to distribute a cash dividend of 2 yuan (including tax) for every 10 shares to all shareholders

### Related Stocks

- [002791.CN](https://longbridge.com/en/quote/002791.CN.md)

## Related News & Research

- [ZAWYA: Al Habtoor Tower: Dubai's boldest residential project yet](https://longbridge.com/en/news/287051508.md)
- [Flow Pharma U.S. Patent Application Allowed for Issuance Covering Broad-Spectrum Ebola Therapy](https://longbridge.com/en/news/287076761.md)
- [Cramer reiterates debt-coverage rule amid high-rate pressures](https://longbridge.com/en/news/287048552.md)
- [05:20 ETThrough the America's Most Artistic Kid Competition, Colossal Raises $1.6 Million While Celebrating the Next Gen of Creative Visionaries](https://longbridge.com/en/news/287037755.md)
- [15:37 ETMuse Communications Celebrates 10 Years of Award-Winning Legal Marketing and Public Relations](https://longbridge.com/en/news/286811115.md)